In vitro susceptibility to various antibiotics of colistin-resistant gram-negative bacterial isolates in a general tertiary hospital in Crete, Greece

Clinical Infectious Diseases

Volumn 50, Issue 12, 2010, Pages 1689-1691

  Samonis, George ^a   Matthaiou, Dimitrios K ^d   Kofteridis, Diamantis ^a   Maraki, Sofia ^b   Falagas, Matthew E ^c,d  

^a Departments of Internal Medicine   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ALFA INSTITUTE OF BIOMEDICAL SCIENCES AIBS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; TETRACYCLINE;

ACINETOBACTER BAUMANNII; ADULT; AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BLOOD SAMPLING; BRONCHUS; CLINICAL ARTICLE; DISK DIFFUSION; FEMALE; GRAM NEGATIVE BACTERIUM; GREECE; HUMAN; IN VITRO STUDY; INTRAVENOUS CATHETER; KLEBSIELLA PNEUMONIAE; LETTER; LUNG LAVAGE; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PUS; SALVAGE THERAPY; SELF EXAMINATION; TERTIARY HEALTH CARE; URINALYSIS;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GREECE; HOSPITALS, GENERAL; HUMANS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PSEUDOMONAS AERUGINOSA; TERTIARY PREVENTION;

EID: 77952989863     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653009     Document Type: Letter

References (11)

1. TalbotGH,BradleyJ,EdwardsJE,GilbertD,ScheldM,BartlettJG.Badbugsneeddrugs: anupdateonthedevelopmentpipelinefromtheAntimicrobialAvailabilityTaskForceoftheI nfectiousDiseasesSocietyofAmerica.ClinInfectDis2006;42:657-668. (Pubitemid43271379)
2. Li J, Nation RL, Turnidge JD, et al. Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis 2006; 6: 589-601. (Pubitemid 44246880)
3. Falagas ME, Rafailidis PI. Re-emergence of Colistin in today's world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs 2008; 17: 973-981.
4. Matthaiou DK, Michalopoulos A, Rafailidis PI, et al. Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study. Crit Care Med 2008; 36: 807-811.
5. Markou N, Markantonis SL, Dimitrakis E, et al. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study. Clin Ther 2008; 30: 143-151. (Pubitemid 351834728)
6. Goldstein FW, Ly A, Kitzis MD. Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to Colistin. J Antimicrob Chemother 2007; 59: 1039-1040.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 17th informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
8. Li J, Nation RL, Owen RJ, Wong S, Spelman D, Franklin C. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains. Clin Infect Dis 2007; 45: 594-598.
9. Ko KS, Suh JY, Kwon KT, et al. High rates of resistance to Colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J Antimicrob Chemother 2007; 60: 1163-1167.
10. Gillespie SH, McHugh TD. The biological cost of antimicrobial resistance. Trends Microbiol 1997; 5: 337-339.
11. Hocquet D, Berthelot P, Roussel-Delvallez M, et al. Pseudomonas aeruginosa may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections. Antimicrob Agents Chemother 2007; 51: 3531-3536.